Aromatic Amino Acid class drugs

6 results
  • carbidopa and levodopa

    (Carbidopa and levodopa)
    Advagen Pharma Ltd
    Carbidopa and levodopa extended-release tablets are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.
  • carbidopa and levodopa

    (carbidopa and levodopa)
    Rising Pharma Holdings, Inc.
    Carbidopa and levodopa orally disintegrating tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism following carbon monoxide or manganese intoxication. Carbidopa enhances levodopa’s effectiveness by reducing peripheral decarboxylation and may also lessen nausea, allowing for quicker dosage adjustments.
  • carbidopa-levodopa

    (carbidopa and levodopa)
    Advagen Pharma Ltd.,
    Carbidopa and levodopa tablets are indicated for treating Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism following carbon monoxide or manganese intoxication. Carbidopa enhances levodopa's effectiveness, allowing lower doses, reducing nausea, and facilitating faster titration.
  • dhivy

    (Carbidopa Levodopa)
    Avion Pharmaceuticals, LLC
    DHIVY is indicated for treating Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.
  • inbrija

    (levodopa)
    Merz Pharmaceuticals, LLC, a subsidiary of Merz Therapeutics GmbH
    INBRIJA is indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease who are receiving carbidopa/levodopa therapy.